Related Experiment Videos
Alloderm acellular dermal graft: applications in aesthetic soft-tissue augmentation
1Plastic Surgery Institute of Southern California, Thousand Oaks 91361, USA.
Clinics in Plastic Surgery
|March 16, 2001
Summary
Alloderm, an acellular human dermal tissue, offers a natural alternative for soft-tissue augmentation, showing excellent integration and low reactivity. Volume persistence requires careful surgical consideration for optimal aesthetic and reconstructive outcomes.
Area of Science:
- Regenerative Medicine
- Biomaterials Science
- Plastic and Reconstructive Surgery
Background:
- Alloplastic materials present challenges in soft-tissue augmentation due to potential tissue reactivity.
- Acellular human dermal tissue, such as Alloderm, has emerged as a potential alternative.
- Evaluating the efficacy and limitations of Alloderm is crucial for its clinical application.
Purpose of the Study:
- To assess the advantages and disadvantages of using Alloderm for soft-tissue augmentation.
- To compare Alloderm's performance against traditional alloplastic materials.
- To determine the clinical utility of Alloderm in aesthetic and reconstructive procedures.
Main Methods:
- Review of clinical outcomes and literature regarding Alloderm implantation.
- Analysis of tissue integration and reactivity following Alloderm use.
- Assessment of volume persistence and long-term results.
Main Results:
- Alloderm demonstrates natural integration into host tissues, minimizing concerns associated with synthetic materials.
- The human origin of Alloderm results in a significantly low incidence of tissue reactivity.
- Volume persistence can be variable, necessitating surgeon-specific evaluation and technique adjustment.
Conclusions:
- Alloderm serves as a successful and natural alternative for soft-tissue augmentation, addressing aesthetic and reconstructive needs.
- The primary concern with Alloderm is variable volume persistence, which can be managed through surgical technique.
- Overall, the benefits of Alloderm, including its biocompatibility, outweigh its limitations in specific clinical scenarios.